Akin helped Pharmakon Advisors, LP and its affiliated funds offer UroGen Pharma Ltd., a biotech business committed to creating and marketing cutting-edge treatments for urothelial other specialized malignancies, a senior secured term loan of up to $250 million in two tranches.